Cognitive Decline: Approach to Diagnosis and Treatment
Registration |
---|
You must log in or create an account before enrolling in this educational activity. Once you register for the course, you will have 30 days from the enrollment date to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage. |
Target Audience
Healthcare professionals.
Educational Need
This presentation will discuss the latest advancements in understanding, evaluating, and treating patients facing cognitive decline. The speakers will equip healthcare professionals with valuable knowledge and practical skills to effectively address the challenges of cognitive decline. Clinicians will be better equipped to provide compassionate and effective care to patients experiencing cognitive challenges.
Objectives
- Evaluate patients with cognitive decline.
- Treat patients with cognitive decline.
- Diagnose the various types of dementia.
- Implement comprehensive care for dementia patients.
Speakers
Robert Bender, MD
Geriatrician
Leonard S. Richards, DO
Associate Program Director, Broadlawns UnityPoint Psychiatry Residency Program
Terms of Use and Privacy Policy
Recording date: November 10, 2023
Date of original release: November 10, 2023
Most recent review/update: November 10, 2023
Termination date: November 9, 2026
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 0.75 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.
Educational Grants
No ineligible company provided financial support for this continuing education activity.
DISCLOSURE
The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.
- Robert Bender, MD - Speaker
- Leonard S. Richards, DO - Speaker
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 0.75 AMA PRA Category 1 Credits™
- 0.75 AOA Category 1B
- 0.75 CE Contact Hour(s)